The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Pharmaceutical giant Merck & Co. was ordered to pay $47.5 million in damages after a New Jersey jury decided that the company’s Vioxx medication was responsible for an Idaho man’s heart attack. The jury awarded $20 million in compensatory damages to Frederick Humeston and his wife and then tacked on an additional $27.5 million in punitive damages after a unanimous decision.

In the first phase of the trial, jurors found that Merck not only violated consumer-fraud laws, but also failed to provide adequate warnings prior to the plaintiff’s Vioxx regimen. Humeston had lost his first trial against Merck. However, that previous verdict was tossed out and a retrial was ordered by Judge Carol Higbee after new evidence came to light.

Today’s verdict concluded the second phase of Humeston’s trial, which was to determine whether or not the drug led directly to his heart attack, which he survived. Jurors decided that Vioxx was indeed responsible for the man’s heart attack, and they also claimed that Humeston’s physician may have chosen alternative treatment had proper warnings about the drug been issued. Humeston’s heart attack occurred in September of 2001 before updated Vioxx product warnings appeared on the label. Therefore, jurors decided, the company was liable for both punitive and compensatory damages.

Comments for this article are closed.